BG Medicine, Inc.
BGMD · OTC
12/31/2015 | 12/31/2014 | 12/31/2013 | 12/31/2012 | |
|---|---|---|---|---|
| Market Cap | $3,507 | $15,076 | $28,301 | $46,699 |
| - Cash | $1,525 | $4,123 | $7,751 | $12,786 |
| + Debt | $0 | $2,960 | $7,314 | $9,857 |
| Enterprise Value | $1,982 | $13,913 | $27,864 | $43,770 |
| Revenue | $1,566 | $2,787 | $4,073 | $2,815 |
| % Growth | -43.8% | -31.6% | 44.7% | – |
| Gross Profit | $1,061 | $1,831 | $2,684 | $1,858 |
| % Margin | 67.8% | 65.7% | 65.9% | 66% |
| EBITDA | -$5,057 | -$7,205 | -$14,756 | -$22,413 |
| % Margin | -322.9% | -258.5% | -362.3% | -796.2% |
| Net Income | -$5,303 | -$8,064 | -$15,849 | -$23,769 |
| % Margin | -338.6% | -289.3% | -389.1% | -844.4% |
| EPS Diluted | -0.55 | -0.99 | -2.33 | -4.7 |
| % Growth | 44.4% | 57.5% | 50.4% | – |
| Operating Cash Flow | -$3,667 | -$8,167 | -$15,288 | -$21,333 |
| Capital Expenditures | $0 | $0 | -$132 | -$85 |
| Free Cash Flow | -$3,667 | -$8,167 | -$15,420 | -$21,418 |